Securities Code: 300723 Securities Abbreviation: Yipin Hong Announcement No.: 2026-033
Yipin Hong Pharmaceutical Group Co., Ltd. Announcement on Wholly-Owned Subsidiary Obtaining Registration Certificate for Procaterol Hydrochloride Oral Solution
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or significant omissions.
Yipin Hong Pharmaceutical Group Co., Ltd. (hereinafter referred to as the "Company") announced that its wholly-owned subsidiary, Guangzhou Yipin Hong Pharmaceutical Co., Ltd., recently received the "Drug Registration Certificate" for Procaterol Hydrochloride Oral Solution, approved and issued by the National Medical Products Administration. The relevant matters are hereby announced as follows:
I. Key Information of the Drug Registration Certificate